Cargando…
Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
BACKGROUND: Edoxaban, an oral direct factor Xa inhibitor, is in development for thromboprophylaxis, including prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). P-glycoprotein (P-gp), an efflux transporter, modulates absorption and excretion of xenobiotics. Edoxaba...
Autores principales: | Mendell, Jeanne, Zahir, Hamim, Matsushima, Nobuko, Noveck, Robert, Lee, Frank, Chen, Shuquan, Zhang, George, Shi, Minggao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781304/ https://www.ncbi.nlm.nih.gov/pubmed/23784266 http://dx.doi.org/10.1007/s40256-013-0029-0 |
Ejemplares similares
-
Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine
por: Parasrampuria, Dolly A., et al.
Publicado: (2016) -
The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
por: Mendell, Jeanne, et al.
Publicado: (2015) -
Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
por: Nabekura, Tomohiro, et al.
Publicado: (2020) -
Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
por: Bounameaux, Henri, et al.
Publicado: (2014) -
Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter
por: Ahn, Misol, et al.
Publicado: (2012)